Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 755.05 INR -1.79% Market Closed
Market Cap: 289.1B INR
Have any thoughts about
Gland Pharma Ltd?
Write Note

Gland Pharma Ltd
Gain/Loss on Disposition of Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gland Pharma Ltd
Gain/Loss on Disposition of Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gain/Loss on Disposition of Assets CAGR 3Y CAGR 5Y CAGR 10Y
Gland Pharma Ltd
NSE:GLAND
Gain/Loss on Disposition of Assets
â‚ą2.5m
CAGR 3-Years
118%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Gain/Loss on Disposition of Assets
â‚ą94.5m
CAGR 3-Years
111%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Gland Pharma Ltd
Glance View

Market Cap
289.1B INR
Industry
Pharmaceuticals

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-11-20. The firm provides a range of injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions. The company provides contract development and manufacturing services, such as evaluation of development needs, identifying application program interface (API) sources, analytical method development, formulation development and product/technology know-how; and manufacturing of registration batches, studies, dossier compilation for regulatory submission and commercial production. The Company’s therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients.

GLAND Intrinsic Value
1 457.5 INR
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Gland Pharma Ltd's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
2.5m INR

Based on the financial report for Mar 31, 2024, Gland Pharma Ltd's Gain/Loss on Disposition of Assets amounts to 2.5m INR.

What is Gland Pharma Ltd's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 5Y
20%

The average annual Gain/Loss on Disposition of Assets growth rates for Gland Pharma Ltd have been 118% over the past three years , 20% over the past five years .

Back to Top